
Donna A. Jagoe
Examiner (ID: 8925)
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1614, 1619 |
| Total Applications | 644 |
| Issued Applications | 169 |
| Pending Applications | 182 |
| Abandoned Applications | 293 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7027033
[patent_doc_number] => 20050020674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Pharmaceutical compositions of short-acting sedative hypnotic agent'
[patent_app_type] => utility
[patent_app_number] => 10/895603
[patent_app_country] => US
[patent_app_date] => 2004-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6490
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020674.pdf
[firstpage_image] =>[orig_patent_app_number] => 10895603
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/895603 | Pharmaceutical compositions of short-acting sedative hypnotic agent | Jul 20, 2004 | Issued |
Array
(
[id] => 5711044
[patent_doc_number] => 20060052389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects'
[patent_app_type] => utility
[patent_app_number] => 10/894349
[patent_app_country] => US
[patent_app_date] => 2004-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 20971
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052389.pdf
[firstpage_image] =>[orig_patent_app_number] => 10894349
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/894349 | Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects | Jul 18, 2004 | Abandoned |
Array
(
[id] => 7265166
[patent_doc_number] => 20040242702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Glutaraldehyde composition'
[patent_app_type] => new
[patent_app_number] => 10/485070
[patent_app_country] => US
[patent_app_date] => 2004-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2762
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242702.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485070
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485070 | Glutaraldehyde composition | Jul 12, 2004 | Abandoned |
Array
(
[id] => 6972308
[patent_doc_number] => 20050038018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Meloxicam compositions'
[patent_app_type] => utility
[patent_app_number] => 10/885260
[patent_app_country] => US
[patent_app_date] => 2004-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6050
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20050038018.pdf
[firstpage_image] =>[orig_patent_app_number] => 10885260
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/885260 | Meloxicam compositions | Jul 5, 2004 | Abandoned |
Array
(
[id] => 7276410
[patent_doc_number] => 20040235861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Method of using flibanserin for neuroprotection'
[patent_app_type] => new
[patent_app_number] => 10/882613
[patent_app_country] => US
[patent_app_date] => 2004-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2419
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10882613
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/882613 | Method of using flibanserin for neuroprotection | Jun 30, 2004 | Abandoned |
Array
(
[id] => 92278
[patent_doc_number] => 07737147
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-15
[patent_title] => 'Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/881911
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5975
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/737/07737147.pdf
[firstpage_image] =>[orig_patent_app_number] => 10881911
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/881911 | Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors | Jun 29, 2004 | Issued |
Array
(
[id] => 7265438
[patent_doc_number] => 20040242974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Treatment of refractory depression with an opiate antagonist and an antidepressant'
[patent_app_type] => new
[patent_app_number] => 10/878285
[patent_app_country] => US
[patent_app_date] => 2004-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7492
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242974.pdf
[firstpage_image] =>[orig_patent_app_number] => 10878285
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/878285 | Treatment of refractory depression with an opiate antagonist and an antidepressant | Jun 28, 2004 | Abandoned |
Array
(
[id] => 7156550
[patent_doc_number] => 20050026979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Methods for treating inflammation and inflammation-associated diseases with a statin and ether'
[patent_app_type] => utility
[patent_app_number] => 10/872023
[patent_app_country] => US
[patent_app_date] => 2004-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15495
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026979.pdf
[firstpage_image] =>[orig_patent_app_number] => 10872023
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/872023 | Methods for treating inflammation and inflammation-associated diseases with a statin and ether | Jun 17, 2004 | Abandoned |
Array
(
[id] => 6996339
[patent_doc_number] => 20050136117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Pharmaceutical formulations'
[patent_app_type] => utility
[patent_app_number] => 10/868104
[patent_app_country] => US
[patent_app_date] => 2004-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5965
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136117.pdf
[firstpage_image] =>[orig_patent_app_number] => 10868104
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/868104 | Pharmaceutical formulations | Jun 14, 2004 | Abandoned |
Array
(
[id] => 5913720
[patent_doc_number] => 20060128782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 10/559252
[patent_app_country] => US
[patent_app_date] => 2004-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3619
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128782.pdf
[firstpage_image] =>[orig_patent_app_number] => 10559252
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559252 | Sublingual Formulations of Ketorolac or Salts Thereof | May 25, 2004 | Issued |
Array
(
[id] => 7005803
[patent_doc_number] => 20050171116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Enhancing the efficacy of tubercular drugs'
[patent_app_type] => utility
[patent_app_number] => 10/851601
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3651
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171116.pdf
[firstpage_image] =>[orig_patent_app_number] => 10851601
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/851601 | Enhancing the efficacy of tubercular drugs | May 20, 2004 | Abandoned |
Array
(
[id] => 7465851
[patent_doc_number] => 20040198633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Identifying parasitic fungi of the organism, and treatment thereof'
[patent_app_type] => new
[patent_app_number] => 10/478508
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2203
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198633.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478508
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478508 | Identifying parasitic fungi of the organism, and treatment thereof | May 10, 2004 | Abandoned |
Array
(
[id] => 7190443
[patent_doc_number] => 20040204399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Aerosolized decongestants for the treatment of sinusitis'
[patent_app_type] => new
[patent_app_number] => 10/835872
[patent_app_country] => US
[patent_app_date] => 2004-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15824
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204399.pdf
[firstpage_image] =>[orig_patent_app_number] => 10835872
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/835872 | Aerosolized decongestants for the treatment of sinusitis | Apr 28, 2004 | Abandoned |
Array
(
[id] => 5154952
[patent_doc_number] => 20070037835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Pharmaceutical composition comprising a cathepsin s inhibitor and an opioid'
[patent_app_type] => utility
[patent_app_number] => 10/554560
[patent_app_country] => US
[patent_app_date] => 2004-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3771
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037835.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554560
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554560 | Pharmaceutical composition comprising a cathepsin s inhibitor and an opioid | Apr 26, 2004 | Abandoned |
Array
(
[id] => 7467366
[patent_doc_number] => 20040198839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Cardioprotective dosage units'
[patent_app_type] => new
[patent_app_number] => 10/828797
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2339
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198839.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828797
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828797 | Cardioprotective dosage units | Apr 20, 2004 | Abandoned |
Array
(
[id] => 6967203
[patent_doc_number] => 20050234100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Insulin resistance as new action of loperamide'
[patent_app_type] => utility
[patent_app_number] => 10/826258
[patent_app_country] => US
[patent_app_date] => 2004-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5282
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20050234100.pdf
[firstpage_image] =>[orig_patent_app_number] => 10826258
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/826258 | Insulin resistance as new action of loperamide | Apr 18, 2004 | Abandoned |
Array
(
[id] => 7435562
[patent_doc_number] => 20040266806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Pharmaceutical formulation'
[patent_app_type] => new
[patent_app_number] => 10/821811
[patent_app_country] => US
[patent_app_date] => 2004-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9952
[patent_no_of_claims] => 209
[patent_no_of_ind_claims] => 78
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266806.pdf
[firstpage_image] =>[orig_patent_app_number] => 10821811
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/821811 | Pharmaceutical formulation | Apr 7, 2004 | Abandoned |
Array
(
[id] => 7329740
[patent_doc_number] => 20040254100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Use of thiostrepton as an anti-mycobacterial agent'
[patent_app_type] => new
[patent_app_number] => 10/182658
[patent_app_country] => US
[patent_app_date] => 2004-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1473
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254100.pdf
[firstpage_image] =>[orig_patent_app_number] => 10182658
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/182658 | Use of thiostrepton as an anti-mycobacterial agent | Apr 4, 2004 | Abandoned |
Array
(
[id] => 7672940
[patent_doc_number] => 20040180839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'D-mannose contraceptives'
[patent_app_type] => new
[patent_app_number] => 10/810522
[patent_app_country] => US
[patent_app_date] => 2004-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1019
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180839.pdf
[firstpage_image] =>[orig_patent_app_number] => 10810522
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/810522 | D-mannose contraceptives | Mar 25, 2004 | Abandoned |
Array
(
[id] => 5142511
[patent_doc_number] => 20070004727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Use of compounds for the prevention of drug-induced cell toxicity'
[patent_app_type] => utility
[patent_app_number] => 10/550488
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10065
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004727.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550488
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550488 | Use of compounds for the prevention of drug-induced cell toxicity | Mar 24, 2004 | Abandoned |